Colgate-Palmolive (India) Ltd's Q2 FY27 numbers came in strong, with revenue of Rs. 1,705.79 Cr (+12.20% YoY) and PAT growth of +4.30% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | October 22, 2026 |
|---|---|
| Quarter | Q2 FY 2026-2027 |
| Revenue (Q2) | Rs. 1,705.79 Cr (+12.20% YoY) |
| PAT (Q2) | Rs. 341.57 Cr (+4.30% YoY) |
| EBITDA margin | 27.75% (-282 bps YoY) |
| EPS (Q2) | Rs. 12.56 (+4.30% YoY) |
| Market cap | Rs. 45,829.58 Cr |
| CMP | Rs. 1,685.00 |
Colgate-Palmolive India delivered 12.2% YoY sales growth to Rs.1,692 Cr with high-single-digit toothpaste volume expansion, marking a second consecutive quarter of double-digit growth. Gross margin expanded 40 bps to 69.6%, but EBITDA margin compressed 282 bps to 27.75% as advertising (15.85% of sales) and other expenses (+27.6%) were deliberately stepped up under the growth-ahead-of-profitability strategy. Management delivered on its stated guidance with a debt-free, cash-rich balance sheet (Rs.1,588 Cr cash, ROCE 121%) supporting the ~100% dividend payout policy.
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.